Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Cancer
Target：
IC50: 0.5 nM (VEGFR2), 5 nM (Flt1), ≤ 3 nM (Flt4)
描述：
Cediranib is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, and also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM, with similar activity against c-Kit and PDGFRβ, 36-, 110-fold and is >1000-fold
m.cnreagent.com
